LONDON--(BUSINESS WIRE)-- As a premier analytics solutions provider, Quantzig has helped leading businesses tackle the disruptions in the current business milieu. As a part of its continued efforts, Quantzig today announced the completion of its latest patient journey analysis engagement. During the course of this engagement, Quantzig successfully collaborated with a leading pharmaceutical corporation in the United States to help them gain a 360° understanding of patients diagnosed with Crohn’s disease.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200505005083/en/

Quantzig’s Value Proposition (Graphic: Business Wire)

Ensuring business stability is a major challenge for businesses amid the crisis. Don’t you agree? We can help you address this challenge using advanced AI-powered analytics solutions that’ll help you turn data points into contextual insights and predictions that drive stronger business decisions. Request a FREE proof of concept for expert insights and personalized recommendations.

To meet the specific requirements of the leading pharma company, our patient journey analysis team analyzed the impact of drug adherence on disease progression and flare-ups based on the analysis of the data collected from various sources. The primary scope of this patient journey analysis was to understand the drug performance in the real world as compared to ideal settings with the help of real world data. The study validated the efficacy of the clinical trials by understanding the disease progression in the patients under the influence of a variety of therapies in the real-world scenario.

Adopting holistic analytics-backed business continuity solutions have helped leading businesses navigate the crisis. Wonder how? Speak to an expert for comprehensive solution insights.

How patient journey analysis helped the pharmaceutical company

We adopted a three-pronged approach to help the client address their challenges. The solution offered more insights on the impact of drug adherence on disease progression and flare-ups. The analytics team identified the patients who have been diagnosed with Crohn’s disease in the client database and considered patient data at the incident level from 3 years before the diagnosis date. They also analyzed the claims data to understand the direct and indirect spending on multiple therapies in order to identify the optimal treatment patterns.

Our approach to patient journey analysis also provided benefits that helped the client to:

• To identify a set of business rules to create a validation framework to understand the efficacy of clinical trials
• Gain insights on the drug performance in the real world as compared to ideal settings
• Conclude that adherence rates are significantly higher in patients with less strength and non-comorbid conditions
• Request a FREE demo to gain a limited-period free license to access our healthcare analytics platform.

According to the healthcare analytics experts at Quantzig,” Most healthcare and pharmaceutical companies are focusing on understanding the patient journey as they operate in a competitive landscape driven by the meaningful use of healthcare regulations that primarily focus on demonstrating efficient use of technology to improve patient care, satisfaction levels, and the overall experience.”

Quantzig offers a comprehensive portfolio of COVID-19 business support solutions:

With over 15+ years of experience in offering advanced marketing analytics solutions, our analytics experts have developed a comprehensive COVID-19 business support solutions portfolio that can help you ensure business continuity by leveraging analytics at strategic points in the value chain. As a part of this package we also offer:

• Free personalized solution consultation with our experts
• Access to a comprehensive library of best practices
• Free license to access our analytics platforms
• Coronavirus impact assessment at no additional cost
• Take advantage of innovative, research-based solutions and subject matter expertise to power innovation and deliver solutions at scale. Learn more.

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal

View source version on businesswire.com: https://www.businesswire.com/news/home/20200505005083/en/